Experienced in Eosinophilic Colitis

Ulrike Von Arnim

Leipziger Str. 44, 
Magdeburg, ST, DE 
Experienced in Eosinophilic Colitis
Leipziger Str. 44, 
Magdeburg, ST, DE 
OverviewLocationsClinical Research

Overview

Ulrike Von Arnim practices in Magdeburg, Germany. Ms. Von Arnim is rated as an Experienced expert by MediFind in the treatment of Eosinophilic Colitis. Her top areas of expertise are Eosinophilic Esophagitis, Esophagitis, Viral Gastroenteritis, Crohn's Disease, and Endoscopy.

Her clinical research consists of co-authoring 40 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Eosinophilic Colitis.

Gender
Female

Locations

Leipziger Str. 44, Magdeburg, ST 39120, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Prospective, Multi-center Registry for Patients With Short Bowel Syndrome
A Prospective, Multi-center Registry for Patients With Short Bowel Syndrome
Enrollment Status: Active_not_recruiting
Publish Date: October 10, 2025
EndoStim Patient Registry-LES Stimulation System for the Treatment of GERD
EndoStim Patient Registry-LES Stimulation System for the Treatment of GERD
Enrollment Status: Terminated
Publish Date: October 15, 2024
Intervention Type: Device
A Phase II, Multicentre, Randomised, Double-blind, Placebo Controlled, Proof of Concept Study of Efficacy and Safety of Rifamycin SV-MMX® 600 mg Tablets Administered Three or Two Times Daily to Patients With Diarrhoea-predominant Irritable Bowel Syndrome (IBS-D)
A Phase II, Multicentre, Randomised, Double-blind, Placebo Controlled, Proof of Concept Study of Efficacy and Safety of Rifamycin SV-MMX® 600 mg Tablets Administered Three or Two Times Daily to Patients With Diarrhoea-predominant Irritable Bowel Syndrome (IBS-D)
Enrollment Status: Completed
Publish Date: January 08, 2021
Intervention Type: Drug
Study Phase: Phase 2
View 2 Less Clinical Trials

40 Total Publications

Real-world-data on efficacy and safety of topical budesonide therapy (orodispersible tablet) in induction and maintenance therapy in adult patients with active eosinophilic esophagitis.
Real-world-data on efficacy and safety of topical budesonide therapy (orodispersible tablet) in induction and maintenance therapy in adult patients with active eosinophilic esophagitis.
Journal: Therapeutic advances in gastroenterology
Published: May 17, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Von Arnim's expertise for a condition
ConditionClose
    View All 17 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile